These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 17929296)

  • 21. The role of the toll-like receptor TLR4 in hepatitis B virus-associated glomerulonephritis.
    Zhou Y; Zhu N; Wang X; Wang L; Gu LJ; Yuan WJ
    Arch Virol; 2013 Feb; 158(2):425-33. PubMed ID: 23076739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
    Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C
    Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance.
    Lan P; Zhang C; Han Q; Zhang J; Tian Z
    Hepatology; 2013 Jul; 58(1):73-85. PubMed ID: 23447417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model.
    Wu J; Huang S; Zhao X; Chen M; Lin Y; Xia Y; Sun C; Yang X; Wang J; Guo Y; Song J; Zhang E; Wang B; Zheng X; Schlaak JF; Lu M; Yang D
    J Virol; 2014 Sep; 88(18):10421-31. PubMed ID: 24920792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes.
    Lucifora J; Bonnin M; Aillot L; Fusil F; Maadadi S; Dimier L; Michelet M; Floriot O; Ollivier A; Rivoire M; Ait-Goughoulte M; Daffis S; Fletcher SP; Salvetti A; Cosset FL; Zoulim F; Durantel D
    Sci Rep; 2018 Mar; 8(1):5390. PubMed ID: 29599452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kupffer Cells Support Hepatitis B Virus-Mediated CD8+ T Cell Exhaustion via Hepatitis B Core Antigen-TLR2 Interactions in Mice.
    Li M; Sun R; Xu L; Yin W; Chen Y; Zheng X; Lian Z; Wei H; Tian Z
    J Immunol; 2015 Oct; 195(7):3100-9. PubMed ID: 26304988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses.
    Ma Z; Zhang E; Yang D; Lu M
    Cell Mol Immunol; 2015 May; 12(3):273-82. PubMed ID: 25418467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
    Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of microRNA-155 correlates positively with the expression of Toll-like receptor 7 and modulates hepatitis B virus via C/EBP-β in hepatocytes.
    Sarkar N; Panigrahi R; Pal A; Biswas A; Singh SP; Kar SK; Bandopadhyay M; Das D; Saha D; Kanda T; Sugiyama M; Chakrabarti S; Banerjee A; Chakravarty R
    J Viral Hepat; 2015 Oct; 22(10):817-27. PubMed ID: 25720442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corticosteroids shift the Toll-like receptor response pattern of primary-isolated murine liver cells from an inflammatory to an anti-inflammatory state.
    Broering R; Montag M; Jiang M; Lu M; Sowa JP; Kleinehr K; Gerken G; Schlaak JF
    Int Immunol; 2011 Sep; 23(9):537-44. PubMed ID: 21750146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon-β response is impaired by hepatitis B virus infection in Tupaia belangeri.
    Kayesh MEH; Ezzikouri S; Chi H; Sanada T; Yamamoto N; Kitab B; Haraguchi T; Matsuyama R; Nkogue CN; Hatai H; Miyoshi N; Murakami S; Tanaka Y; Takano JI; Shiogama Y; Yasutomi Y; Kohara M; Tsukiyama-Kohara K
    Virus Res; 2017 Jun; 237():47-57. PubMed ID: 28551415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kupffer cells interact with hepatitis B surface antigen in vivo and in vitro, leading to proinflammatory cytokine production and natural killer cell function.
    Boltjes A; van Montfoort N; Biesta PJ; Op den Brouw ML; Kwekkeboom J; van der Laan LJ; Janssen HL; Boonstra A; Woltman AM
    J Infect Dis; 2015 Apr; 211(8):1268-78. PubMed ID: 25362194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Toll-like receptor 2 in the immune response against hepadnaviral infection.
    Zhang X; Ma Z; Liu H; Liu J; Meng Z; Broering R; Yang D; Schlaak JF; Roggendorf M; Lu M
    J Hepatol; 2012 Sep; 57(3):522-8. PubMed ID: 22617154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
    Miyazaki M; Kanto T; Inoue M; Itose I; Miyatake H; Sakakibara M; Yakushijin T; Kakita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    J Med Virol; 2008 Jun; 80(6):980-8. PubMed ID: 18428149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein.
    Visvanathan K; Skinner NA; Thompson AJ; Riordan SM; Sozzi V; Edwards R; Rodgers S; Kurtovic J; Chang J; Lewin S; Desmond P; Locarnini S
    Hepatology; 2007 Jan; 45(1):102-10. PubMed ID: 17187404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
    Gill N; Deacon PM; Lichty B; Mossman KL; Ashkar AA
    J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The incidence and significance of pattern-recognition receptors in chronic viral hepatitis types B and C in man.
    Mozer-Lisewska I; Sikora J; Kowala-Piaskowska A; Kaczmarek M; Dworacki G; Zeromski J
    Arch Immunol Ther Exp (Warsz); 2010 Aug; 58(4):295-302. PubMed ID: 20533094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TLR3 Activation of Hepatic Stellate Cell Line Suppresses HBV Replication in HepG2 Cells.
    Zhang B; Liu Y; Wang X; Li J; Xu X; Guo L; Ho WZ
    Front Immunol; 2018; 9():2921. PubMed ID: 30619284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Local Stimulation of Liver Sinusoidal Endothelial Cells with a NOD1 Agonist Activates T Cells and Suppresses Hepatitis B Virus Replication in Mice.
    Huang S; Zou S; Chen M; Gao X; Chen L; Yang X; Yu Q; Zhao X; Du Y; Yang X; Lin Y; Wang B; Lu Y; Liu J; Zheng X; Gong F; Lu M; Yang D; Wu J
    J Immunol; 2018 May; 200(9):3170-3179. PubMed ID: 29592964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hippo Pathway Counter-Regulates Innate Immunity in Hepatitis B Virus Infection.
    Luo X; Zhang R; Lu M; Liu S; Baba HA; Gerken G; Wedemeyer H; Broering R
    Front Immunol; 2021; 12():684424. PubMed ID: 34113355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.